Curis Lifesciences Quarterly Results for Trading Insights
CURIS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QJun 2024
Curis Lifesciences Quarterly Results Analysis
| Metric | Jun 2024 | QoQ | YoY |
|---|---|---|---|
| Revenue (₹ Cr) | 9 | - | - |
| Net Profit (₹ Cr) | 1 | - | - |
| EBITDA (₹ Cr) | 3 | - | - |
| EPS (₹) | 24.00 | - | - |
| Operating Margin (%) | 30.0% | - | - |
Curis Lifesciences Share Price Trend Around Quarterly Results
Visualize Curis Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Curis Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Curis Lifesciences
Additional stock information and data for CURIS
Sector Competitors - Quarterly Performance Comparison
Comparing Curis Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores